Abivax S.A.
Stock Exchange Euronext Paris
EPS
EUR1.57
Market Cap
EUR76.58 M
Shares Outstanding
9.9 M
Public Float
5 M

Profile

Address
5, rue de la Baume
Paris Ile-de-France 75008
France
Employees -
Website http://www.abivax.com
Updated 07/08/2019
Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis.

Financials

View All
Created with Highcharts 5.0.14Abivax S.A.Net Income. Fiscal year is January-December. All values EUR Thousands.5 8935 8938 0998 09915 95415 95414 30814 30811 22311 22315 82315 82320132014201520162017201805k10k15k20k
Created with Highcharts 5.0.14Abivax S.A.Sales/Revenue. Fiscal year is January-December. All values EUR Thousands.7373656500000099992013201420152016201720180255075100125

Philippe Pouletty
Chairman
Jean-Jacques Bertrand
Director